ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $14,000 | -50.0% | 88 | -58.3% | 0.00% | -50.0% |
Q2 2021 | $28,000 | +3.7% | 211 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $27,000 | -20.6% | 211 | +3.9% | 0.01% | -25.0% |
Q4 2020 | $34,000 | -5.6% | 203 | -14.0% | 0.01% | -20.0% |
Q3 2020 | $36,000 | +16.1% | 236 | +11.8% | 0.01% | 0.0% |
Q2 2020 | $31,000 | +24.0% | 211 | -6.6% | 0.01% | 0.0% |
Q1 2020 | $25,000 | -3.8% | 226 | +18.9% | 0.01% | +42.9% |
Q4 2019 | $26,000 | – | 190 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 10,719,555 | $1,003,779,130 | 19.76% |
Q Global Advisors, LLC | 285,000 | $26,687 | 17.16% |
Finepoint Capital LP | 163,772 | $15,335,610 | 7.64% |
Avoro Capital Advisors LLC | 3,670,000 | $343,658,800 | 5.36% |
Spyglass Capital Management LLC | 614,618 | $57,552,830 | 4.51% |
Sofinnova Investments, Inc. | 754,032 | $70,607,556 | 4.45% |
Saturn V Capital Management LP | 112,473 | $10,531,972 | 4.41% |
DAFNA Capital Management LLC | 136,212 | $12,754,892 | 3.97% |
ARS Investment Partners, LLC | 285,918 | $26,773,362 | 3.32% |
Ghost Tree Capital, LLC | 85,000 | $7,959,400 | 2.62% |